The Streptococcus pneumoniae urinary antigen test (SPUAT) (Binax Now, USA) was developed for detecting polysaccharide C in urine samples for rapid diagnosis of pneumococcal pneumonia, the most common cause of community-acquired pneumonia (CAP). To validate positive results of these tests, we retrospectively investigated all positive results obtained from the emergency room of a Korean university hospital among patients with suspected CAP. Methods: One hundred twenty-three positive SPUAT results were abstracted and analyzed from the authors' laboratory information system among the SPUAT results performed from 1,143 pneumonic patients admitted from the emergency room of a university hospital between 2007 and 2008. Medical records, including conventional microbiologic analysis results, were reviewed in detail for all positive test results. Results: Among 123 patients with the positive SPUAT results, 24 patients were excluded due to hospitalization history during the preceding month. Nine of 99 patients (9.1%) with suspected CAP had confirmed pneumococcal pneumonia upon conventional sputum or blood culture. Thirty-five positive results (35.4%) showed other microorganisms upon conventional methods, which might be due to possible cross-reactivity. Among those, 23 positive results were considered bacterial pneumonic agents, and 12 positive results were regarded as urinary tract infection strains or contaminating agents. Fifty-five positive SPUAT results (55.6%) showed negative conventional microbiologic growth, and some positive SPUAT results might be caused by true pneumococcal infection although without cultural evidence. Conclusion: Our retrospective study demonstrated that a positive SPUAT result typically does not agree well with conventional culture methods, suggesting that the value of a positive SPUAT result in etiology determination may be limited under practical conditions in a university hospital. (Korean J Clin Microbiol 2010;13:14-18)
INTRODUCTION
Streptococcus pneumoniae is the most common cause of community-acquired pneumonia (CAP) worldwide [1] . The diagnosis of pneumococcal infection traditionally requires recovery of the microorganism from an uncontaminated specimen [2] [3] [4] . However, blood cultures are positive in only about one fourth of cases, and prior antibiotic therapy significantly reduces the likelihood of obtaining a positive blood culture. Cultures of expectorated sputum only provide a probable diagnosis because pneumococcal organisms are often carried in the oropharynx. In order to increase the number of etiologic diagnoses, a Streptococcus pneumoniae urinary antigen test (SPUAT) (Binax Now, Portland, ME, USA) was developed for detecting polysaccharide C in urine samples via a new immunochromatographic method [5] [6] [7] [8] . The introduction of SPUAT in clinical practice has increased the incidence of this etiological diagnosis [9] . The test has proven to be rapid, sensitive, and specific in diagnosing pneumococcal pneumonia in adults [7] [8] [9] . However, due to persistent excretion of urinary antigen [10] or higher cross-reactivity with another pathogen [11] , questions remain concerning the clinical usefulness of SPUAT tests. The clinical utility of a diagnostic test is determined not only by laboratory factors such as sensitivity, specificity, and ease of use, but also by such factors as the epidemiology of the target pathogen and the patterns of test usage. It is to be expected, therefore, that some diagnostic tests have excellent operating characteristics, yet provide no useful clinical information in actual practice. The aim of this study was to investigate the clinical implications of positive SPUAT results in patients with suspected CAP admitted from the emergency room of a university hospital. 
MATERIALS AND METHODS

Materials
We enrolled the adult patients who were admitted from the emergency room for suspected CAP and who underwent a SPUAT between January 2007 and December 2008. Among enrolled patients, the positive SPUAT results were abstracted and analyzed from the authors' laboratory information system. Patients were excluded from this study if their medical records were not available for review. The clinical criteria for CAP were acute illness, radiological signs of pulmonary consolidation, at least two of five signs and symptoms (fever of ＞37.8 o C, dyspnea, cough, pleuritic chest pain, and abnormal lung auscultation), and lack of hospitalization during the preceding month (except for transfer due to same event).
Data collection
Among the 1,143 patients performed the SPUAT test, the medical records of the 123 patients with the positive SPUAT results were reviewed carefully. At chart review, the following data were recorded: age, sex, medical record number, sample type, sample collection method, clinical history, prior antibiotic therapy history, admission history during the preceding month, antibiotic therapy, culture results from any source, SPUAT results from urine, gram stain results from any source, clinical impression, and radiological findings.
S. pneumoniae urinary antigen test
Non-concentrated urine was used for SPUAT according to the instructions of the manufacturer. The result was read visually after 15 minutes and was interpreted on the basis of the presence or absence of a detectable pink to purple lane.
RESULTS
Among the 1,143 patients with available SPUAT results, 123 (10.8%) showed positive SPUAT results. Twenty-four of these 123 patients were excluded because they had hospitalization during the preceding month and were diagnosed as having hospital-acquired pneumonia. Eighty-nine of the 99 patients who met the criteria for CAP (89.9%) had more than one underlying disease, and 43 patients (43.4%) had prior antibiotic treatment history. The demographic characteristics of these patients are shown in Table 1 . Only nine (9.1%) of the pneumonic patients had pneumococcal pneumonia with positive sputum culture results (N=7) and positive blood culture results (N=2). Four (44.4%) of these nine patients had prior antibiotic treatment history.
Thirty-five (35.4%) patients had cultural evidence with positive sputum culture results (N=25) and positive blood culture results (N=10) ( Table 2 ). These microorganisms were regarded as the possible causative agents through SPUAT cross-reactivity. Twenty-three patients (23.2%) with proven microorganisms such as Klebsiella pneumoniae (N=7), Staphylococcus aureus (N=6), Pseudomonas aeruginosa (N=5), Acinetobacter baumannii (N=2), Stenotrophomonas maltophilia (N=1), Streptococcus agalactiae (N=1), and Klebsiella ornithinolytica (N=1) were diagnosed as having bacterial pneumonia. Another 12 patients (12.1%) showed microbial growth such as coagulase-negative Staphylococcus, alpha-hemolytic Streptococcus, yeast, Escherichia coli, Proteus vulgaris, and Enterococcus fecalis, however, we considered these microorganisms to be the etiologic agent of urinary tract infection or contamination. Therefore, no etiology was determined in more than half (N=67, 67.7%) of the pneumonic patients including 12 (12.1%) positive SPUAT results regarded as urinary tract infection or contamination and 55 (55.6%) positive results with negative conventional microbiologic growth in our study group.
DISCUSSION
Compared with conventional culture methods used as the gold standard, the presenting findings showed that positive SPUAT results had a low positive agreement results, a high false-positive rate, with high cross-reactivity with other bacterial strains. Although these tests for diagnosing pneumococcal pneumonia have traditionally compared with conventional culture methods, the gold standard is of limited sensitivity. Given the absence of a gold standard with good sensitivity, the precise significance and performance of these tests cannot be assessed.
Possible false-positive or cross-reacting microorganisms in this study included gram-positive and gram-negative bacterial strains ( Table 2) . As alpha-hemolytic Streptococci contain cell wall components similar to the pneumococcal C polysaccharide, they have been shown to yield false-positive SPUAT results [12] . Charkaluk et al [13] reported that Staphylococcus and Streptococcus species showed cross-reactivity with SPUAT. In the current study, pneumococcal capsular polysaccharides also cross-reacted with gram-negative strains such as E. coli, Klebsiella species, P. aeruginosa, A. baumannii, S. maltophilia, and E. fecalis. Previously, Stalin et al [12] also demonstrated that an in-house serotype-specific latex agglutination (LA) test developed by the Streptococcus Unit at Statens Serum Institut (Copenhagen, Denmark) yielded false-positive LA results with strains of E. coli, Klebsiella species, and Neisseria meningitidis. SPUAT can detect the common C polysaccharide antigen seen in these 90 serotypes, and any component of gram-negative bacteria might react with SPUAT. However, in such cases, we could not exclude true S. pneumoniae infection or nasopharyngeal colonization, which could also explain the positive SPUAT results.
No etiology was determined in more than half the pneumonic patients in this study. Unknown etiology with a positive SPUAT is an obvious clinical problem, and a positive SPUAT is not helpful if bacteriologic confirmation of pneumococcal pneumonia is questionable. In some studies, it has been hypothesized that most of these patients have undetected pneumococcal pneumonia and that an alternative test, like a urinary antigen assay, can improve diagnosis [9, 14, 15] . Therefore, true pneumococcal infection without cultural evidence of infection should be considered.
Other possible explanations of false-positive results include insufficient specimen for culture, prior antibiotic administration, persistent urinary antigen excretion after prior pneumococcal pneumonia, non-specific cross-reactivity, nasopharyngeal colonization with S. pneumoniae, systemic absorption of S. pneumoniae antigen, contamination of urine by skin flora, and no detectable serological or virological cultures. Although Marcos et al. [16] showed that pneumococcal carriage in adults was not associated with SPUAT positivity in eight patients, Stalin et al [12] showed that one of five carriers had weakly positive results. Thus, pneumococcal carriage may cause false-positive results in adults. As the rate of nasopharyngeal colonization in adults is lower than that in children, nasopharyngeal colonization is less important in the former. Persistence of both capsular antigens and C polysaccharide in the urine has been demonstrated after pneumococcal pneumonia [16, 17] . Thus, positivity due to previous pneumococcal infection should always be considered in urine antigen-positive patients. Recent vaccination with pneumococcal polysaccharide vaccine might also explain the presence of pneumococcal antigen in the urine. Urine is a convenient sample in which to detect capsular antigen; however, contaminating flora in samples obtained in a non-sterile manner may cause false-positive SPUAT results.
Although certain risk factors, clinical features, and laboratory abnormalities may suggest a diagnosis of pneumococcal pneumonia, differentiation from common bacterial pneumonias is usually difficult in clinical practice. Before emergency room arrival, 43.4% of patients are given antibiotics. Almost 90% of patients in this study had underlying diseases such as chronic obstructive pulmonary disease, neoplasia, or tuberculosis. The treatment strategy would not have changed according to the SPUAT results under many actual scenarios. Many previous studies have demonstrated that SPUAT has high specificity and high negative predictive values in adults with CAP [14, [18] [19] [20] [21] [22] . These findings indicate that a negative result may be more useful than a positive one is in clinical practice.
This SPUAT test was recently recommended for diagnostic use by the Infectious Diseases Society of America [4] . However, it is not clear how SPUAT should be used and interpreted. Dominguez et al. suggested that the specificity of the test could be enhanced if result lines weaker than the control line were considered negative [7] . Stalin et al suggested using unconcentrated urine and dividing SPUAT-positive results into strong and weak positivity [12] . While weak SPUAT positivity should be interpreted with caution, strong positivity should be considered indicative of pneumococcal etiology in adult CAP. When weak SPUAT positivity was interpreted as positive, SPUAT showed low specificity and a low positive predictive value. Because of the low specificity, weakly SPUAT-positive results appear to be unreliable for diagnostic use. The low positive predictive values of SPUAT discourage their use in order to rule out a pneumococcal etiology in CAP. Therefore, it might be wise to consider weak SPUAT positivity as negative in patients with underlying disease in a large university hospital setting. Unfortunately, we did not divide results into strong and weak positivity. Recently, new, more specific methods have been developed to differentiate patients with and without pneumococcal infection [23] .
There are some limitations to this study. First, it was retrospective in nature. Second, we reviewed only positive SPUAT results. Therefore, we did not estimate the specificity or negative predictive value. Third, we did not include enough serological tests or virological cultures to determine the cause of CAP.
In conclusion, we demonstrated that a positive SPUAT result had a low positive agreement results with conventional cultures, suggesting that the value of a positive SPUAT result in etiology determination may be limited under actual clinical conditions. Further research is needed to delineate the possible effects of prior antibiotic administration on the false-positive rate. 
